Fonte: Journal of immunotherapy. Nome do evento: Annual scientific meeting of the international society for biological therapy of cancer. Unidades: FM, FMRP
Assuntos: IMUNOTERAPIA, CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS DE CABEÇA E PESCOÇO, PROLIFERAÇÃO CELULAR
ABNT
MICHALUART, Pedro et al. Phase I/II trial of DNA-HSP65 immunotherapy for advanced squamous cell carcinoma of the head and neck: toxicity and response. Journal of immunotherapy. Hagerstown: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://ovidsp.tx.ovid.com/sp-3.12.0b/ovidweb.cgi?WebLinkFrameset=1&S=OGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&returnUrl=ovidweb.cgi%3fMain%2bSearch%2bPage%3d1%26S%3dOGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&directlink=http%3a%2f%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCOBOFOKMJ00%2ffs046%2fovft%2flive%2fgv023%2f00002371%2f00002371-200711000-00009.pdf&filename=Abstracts+for+the+22nd+Annual+Scientific+Meeting+of+the+International+Society+for+Biological+Therapy+of. Acesso em: 23 ago. 2024. , 2007APA
Michaluart, P., abdallah, K., Lima, F. D., Smith, R. B., Moyses, R. A., Coelho, V., et al. (2007). Phase I/II trial of DNA-HSP65 immunotherapy for advanced squamous cell carcinoma of the head and neck: toxicity and response. Journal of immunotherapy. Hagerstown: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://ovidsp.tx.ovid.com/sp-3.12.0b/ovidweb.cgi?WebLinkFrameset=1&S=OGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&returnUrl=ovidweb.cgi%3fMain%2bSearch%2bPage%3d1%26S%3dOGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&directlink=http%3a%2f%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCOBOFOKMJ00%2ffs046%2fovft%2flive%2fgv023%2f00002371%2f00002371-200711000-00009.pdf&filename=Abstracts+for+the+22nd+Annual+Scientific+Meeting+of+the+International+Society+for+Biological+Therapy+ofNLM
Michaluart P, abdallah K, Lima FD, Smith RB, Moyses RA, Coelho V, Victora GD, Silva AS, Volsi EC, Kalil Filho JE, Bladés CRZ, Ferraz AR, Barreto AK, Chammas MC, Gomes RL, Gebrim E, Lica A-S, Fernandes KP, Lotufo PA, Cardoso MR, Silva CL. Phase I/II trial of DNA-HSP65 immunotherapy for advanced squamous cell carcinoma of the head and neck: toxicity and response [Internet]. Journal of immunotherapy. 2007 ; 30( 8): 898.[citado 2024 ago. 23 ] Available from: http://ovidsp.tx.ovid.com/sp-3.12.0b/ovidweb.cgi?WebLinkFrameset=1&S=OGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&returnUrl=ovidweb.cgi%3fMain%2bSearch%2bPage%3d1%26S%3dOGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&directlink=http%3a%2f%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCOBOFOKMJ00%2ffs046%2fovft%2flive%2fgv023%2f00002371%2f00002371-200711000-00009.pdf&filename=Abstracts+for+the+22nd+Annual+Scientific+Meeting+of+the+International+Society+for+Biological+Therapy+ofVancouver
Michaluart P, abdallah K, Lima FD, Smith RB, Moyses RA, Coelho V, Victora GD, Silva AS, Volsi EC, Kalil Filho JE, Bladés CRZ, Ferraz AR, Barreto AK, Chammas MC, Gomes RL, Gebrim E, Lica A-S, Fernandes KP, Lotufo PA, Cardoso MR, Silva CL. Phase I/II trial of DNA-HSP65 immunotherapy for advanced squamous cell carcinoma of the head and neck: toxicity and response [Internet]. Journal of immunotherapy. 2007 ; 30( 8): 898.[citado 2024 ago. 23 ] Available from: http://ovidsp.tx.ovid.com/sp-3.12.0b/ovidweb.cgi?WebLinkFrameset=1&S=OGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&returnUrl=ovidweb.cgi%3fMain%2bSearch%2bPage%3d1%26S%3dOGPKFPOBMJDDEEOKNCMKOFOBCIMPAA00&directlink=http%3a%2f%2fgraphics.tx.ovid.com%2fovftpdfs%2fFPDDNCOBOFOKMJ00%2ffs046%2fovft%2flive%2fgv023%2f00002371%2f00002371-200711000-00009.pdf&filename=Abstracts+for+the+22nd+Annual+Scientific+Meeting+of+the+International+Society+for+Biological+Therapy+of